Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Not long until the AGM

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jun 16, 2022 9:22pm

160 Views

Post# 34763249

RE:RE:RE:RE:RE:RE:Not long until the AGM

Details on patients is material info as it can influence the share price, so it has to be released to all, at the same time.

So the AGM cannot be the place, contrary the the beliefs of some here. You have to know the rules that companies have to follow and that are imposed by regulators.
Details on patients is material info as it can influence the share price, so it has to be release to all, at the same time.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing